David Luque-Paz

682 total citations
28 papers, 234 citations indexed

About

David Luque-Paz is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, David Luque-Paz has authored 28 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Infectious Diseases. Recurrent topics in David Luque-Paz's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). David Luque-Paz is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). David Luque-Paz collaborates with scholars based in France, Spain and Cameroon. David Luque-Paz's co-authors include Pierre Tattevin, Inès Lakbar, Marc Léone, Sharon Einav, Jean‐Louis Mège, S. Jouneau, Laurent Vernhet, Mathieu Léderlin, Pierre Chauvin and Matthieu Revest and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Journal of Antimicrobial Chemotherapy.

In The Last Decade

David Luque-Paz

24 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Luque-Paz France	10	63	59	51	30	26	28	234
Francesc Puchades Gimeno Spain	7	154 2.4×	85 1.4×	34 0.7×	15 0.5×	35 1.3×	15	252
J Háber United States	7	158 2.5×	102 1.7×	52 1.0×	35 1.2×	23 0.9×	19	320
Nazlım Aktuğ Demir Türkiye	10	46 0.7×	86 1.5×	22 0.4×	15 0.5×	46 1.8×	49	290
Paul Skorup Sweden	8	43 0.7×	63 1.1×	84 1.6×	8 0.3×	15 0.6×	23	243
Alessandra Santisi Italy	9	107 1.7×	100 1.7×	47 0.9×	26 0.9×	39 1.5×	17	338
Diptesh Aryal Nepal	7	55 0.9×	25 0.4×	66 1.3×	16 0.5×	15 0.6×	22	221
Hugo Guillermo Ternavasio‐de la Vega Spain	8	61 1.0×	82 1.4×	25 0.5×	9 0.3×	26 1.0×	16	203
Ahmed Abdalazim Dafallah Albashir Sudan	7	118 1.9×	42 0.7×	24 0.5×	19 0.6×	30 1.2×	13	325
Handan Alay Türkiye	8	75 1.2×	54 0.9×	18 0.4×	15 0.5×	27 1.0×	48	197
Mehrdad Haghighi Iran	11	115 1.8×	44 0.7×	26 0.5×	52 1.7×	14 0.5×	45	320

Countries citing papers authored by David Luque-Paz

Since Specialization

Citations

This map shows the geographic impact of David Luque-Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Luque-Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Luque-Paz more than expected).

Fields of papers citing papers by David Luque-Paz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Luque-Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Luque-Paz. The network helps show where David Luque-Paz may publish in the future.

Co-authorship network of co-authors of David Luque-Paz

This figure shows the co-authorship network connecting the top 25 collaborators of David Luque-Paz. A scholar is included among the top collaborators of David Luque-Paz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Luque-Paz. David Luque-Paz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marchand‐Adam, S., et al.. (2025). Thoracic Ultrasound for Acute Dyspnea in Interstitial Lung Disease. Journal of Clinical Medicine. 14(12). 4159–4159.

Meschiari, Marianna, Giusy Tiseo, David Luque-Paz, et al.. (2024). Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases. International Journal of Antimicrobial Agents. 64(1). 107186–107186. 12 indexed citations

Bot, Audrey Le, David Luque-Paz, Marie‐Clémence Verdier, et al.. (2024). Voriconazole as an alternative oral treatment in fluconazole-resistant urinary candidiasis. Infectious Diseases Now. 54(6). 104955–104955.

Martin‐Blondel, Guillaume, Audrey Le Bot, David Luque-Paz, et al.. (2024). β-Lactam Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis. JAMA Network Open. 7(12). e2451353–e2451353. 3 indexed citations

Luque-Paz, David, et al.. (2024). Efficacy and safety of antibiotics targeting Gram-negative bacteria in nosocomial pneumonia: a systematic review and Bayesian network meta-analysis. Annals of Intensive Care. 14(1). 66–66. 2 indexed citations

Luque-Paz, David, et al.. (2023). Validation of a short turnaround time automated method for the 24/7 determination of plasma d-lactate on Roche Cobas c502. Practical Laboratory Medicine. 36. e00317–e00317.

Luque-Paz, David, Céline René, Nicolas Collet, et al.. (2023). Early detection of plasma d-lactate: Toward a new highly-specific biomarker of bacteraemia?. Heliyon. 9(6). e16466–e16466. 6 indexed citations

Rolland‐Debord, Camille, David Luque-Paz, Pascaline Choinier, et al.. (2023). Prognostic value of serum Krebs von den Lungen-6 (KL-6) levels in COVID-19 pneumonia. Respiratory Medicine and Research. 84. 101054–101054. 2 indexed citations

Poizeau, F., Sandrine Kerbrat, Frédéric Balusson, et al.. (2022). The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 114(5). 686–694. 13 indexed citations

10.

Jouneau, S., Chloé Rousseau, Mathieu Léderlin, et al.. (2022). Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients. Clinical Nutrition. 41(6). 1335–1342. 26 indexed citations

11.

Luque-Paz, David, et al.. (2022). Incidence and characteristics of COVID-19 in French professional football players during the 2020–2021 season. Infectious Diseases Now. 52(6). 371–373.

12.

Saade, Anastasia, David Luque-Paz, M. Baldeyrou, et al.. (2022). Microbiology and antibiotics after second-stage revision of periprosthetic joint infections: A two-year follow-up cohort. Infectious Diseases Now. 52(6). 358–364. 3 indexed citations

13.

Chauvin, Pierre, Claudie Morzadec, B. de Latour, et al.. (2022). Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis. Innate Immunity. 28(3-4). 138–151. 5 indexed citations

14.

Luque-Paz, David, Pierre Chauvin, F. Poizeau, et al.. (2021). Intrapleural use of urokinase and DNase in pleural infections managed with repeated thoracentesis: A comparative cohort study. PLoS ONE. 16(9). e0257339–e0257339. 9 indexed citations

15.

Reizine, Florian, Agathe Delbove, Alexandre Dos Santos, et al.. (2021). Clinical spectrum and risk factors for mortality among seawater and freshwater critically ill drowning patients: a French multicenter study. Critical Care. 25(1). 372–372. 8 indexed citations

16.

Chenouard, Rachel, Rafaël Mahieu, David Luque-Paz, et al.. (2021). Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model. PLoS ONE. 16(3). e0248177–e0248177. 13 indexed citations

17.

Jouneau, S., Chloé Rousseau, Alain Lescoat, et al.. (2021). Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study. Academic Radiology. 29. S191–S201. 12 indexed citations

18.

Luque-Paz, David, Matthieu Revest, François Eugène, et al.. (2021). Ventriculitis: A Severe Complication of Central Nervous System Infections. Open Forum Infectious Diseases. 8(6). ofab216–ofab216. 24 indexed citations

19.

Lakbar, Inès, David Luque-Paz, Jean‐Louis Mège, Sharon Einav, & Marc Léone. (2020). COVID-19 gender susceptibility and outcomes: A systematic review. PLoS ONE. 15(11). e0241827–e0241827. 44 indexed citations

20.

Luque-Paz, David, Charlotte Pronier, S. Jouneau, et al.. (2020). Incidence and characteristics of nosocomial influenza in a country with low vaccine coverage. Journal of Hospital Infection. 105(4). 619–624. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact